Literature DB >> 12919946

Endothelin B receptor deficiency predisposes to pulmonary edema formation via increased lung vascular endothelial cell growth factor expression.

Todd Carpenter1, Stacey Schomberg, Wolfgang Steudel, John Ozimek, Kelley Colvin, Kurt Stenmark, D Dunbar Ivy.   

Abstract

Endothelin (ET) may contribute to pulmonary edema formation, particularly under hypoxic conditions, and decreases in ET-B receptor expression can lead to reduced ET clearance. ET increases vascular endothelial cell growth factor (VEGF) production in vitro, and VEGF overexpression in the lung causes pulmonary edema in vivo. We hypothesized that pulmonary vascular ET-B receptor deficiency leads to increased lung ET, that excess ET increases lung VEGF levels, promoting pulmonary edema formation, and that hypoxia exaggerates these effects. We studied these hypotheses in ET-B receptor-deficient rats. In normoxia, homozygous ET-B-deficient animals had significantly more lung vascular leak than heterozygous or control animals. Hypoxia increased vascular leak regardless of genotype, and hypoxic ET-B-deficient animals leaked more than hypoxic control animals. ET-B-deficient animals had higher lung ET levels in both normoxia and hypoxia. Lung HIF-1alpha and VEGF content was greater in the ET-B-deficient animals in both normoxia and hypoxia, and both HIF-1alpha and VEGF levels were reduced by ET-A receptor antagonism. Both ET-A receptor blockade and VEGF antagonism reduced vascular leak in hypoxic ET-B-deficient animals. We conclude that ET-B receptor-deficient animals display an exaggerated lung vascular protein leak in normoxia, that hypoxia exacerbates that leak, and that this effect is in part attributable to an ET-mediated increase in lung VEGF content.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12919946     DOI: 10.1161/01.RES.0000090994.15442.42

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  11 in total

1.  Regional quantification of muscarinic acetylcholine receptors and β-adrenoceptors in human airways.

Authors:  T Ikeda; A S M Anisuzzaman; H Yoshiki; M Sasaki; T Koshiji; J Uwada; A Nishimune; H Itoh; I Muramatsu
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

Review 2.  Hypoxia-inducible factor (HIF) and HIF-stabilizing agents in neonatal care.

Authors:  Angela M Park; Timothy A Sanders; Emin Maltepe
Journal:  Semin Fetal Neonatal Med       Date:  2010-07-04       Impact factor: 3.926

3.  Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension.

Authors:  D Dunbar Ivy; Ivan F McMurtry; Kelley Colvin; Masatoshi Imamura; Masahiko Oka; Dong-Seok Lee; Sarah Gebb; Peter Lloyd Jones
Journal:  Circulation       Date:  2005-05-31       Impact factor: 29.690

4.  Hypocapnic but not metabolic alkalosis impairs alveolar fluid reabsorption.

Authors:  Pavlos M Myrianthefs; Arturo Briva; Emilia Lecuona; Vidas Dumasius; David H Rutschman; Karen M Ridge; George J Baltopoulos; Jacob Iasha Sznajder
Journal:  Am J Respir Crit Care Med       Date:  2005-03-11       Impact factor: 21.405

Review 5.  Role of endothelin-1 in acute lung injury.

Authors:  Alejandro P Comellas; Arturo Briva
Journal:  Transl Res       Date:  2009-03-20       Impact factor: 7.012

6.  Endothelial deletion of hypoxia-inducible factor-2alpha (HIF-2alpha) alters vascular function and tumor angiogenesis.

Authors:  Nicolas Skuli; Liping Liu; Anja Runge; Tao Wang; Lijun Yuan; Sunny Patel; Luisa Iruela-Arispe; M Celeste Simon; Brian Keith
Journal:  Blood       Date:  2009-05-13       Impact factor: 22.113

Review 7.  Vascular endothelial growth factors in pulmonary edema: an update.

Authors:  Ioanna Kosmidou; Dimitrios Karmpaliotis; Ajay J Kirtane; Hal V Barron; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2007-06-07       Impact factor: 2.300

8.  EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia.

Authors:  Melissa A Cercone; William Schroeder; Stacey Schomberg; Todd C Carpenter
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-08-14       Impact factor: 5.464

9.  Genetic delivery of bevacizumab to suppress vascular endothelial growth factor-induced high-permeability pulmonary edema.

Authors:  Masaki Watanabe; Julie L Boyer; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2009-06       Impact factor: 5.695

10.  Bacillus anthracis edema toxin inhibits hypoxic pulmonary vasoconstriction via edema factor and cAMP-mediated mechanisms in isolated perfused rat lungs.

Authors:  Xizhong Cui; Jeffrey Wang; Yan Li; Zoe G Couse; Thomas F Risoleo; Mahtab Moayeri; Stephen H Leppla; Daniela Malide; Zu-Xi Yu; Peter Q Eichacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-10-16       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.